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Abstract. 
 
Laminin 5 regulates anchorage and motility 
 
of epithelial cells through integrins 
 
a
 
6
 
b
 
4 and 
 
a
 
3
 
b
 
1, re-
 
spectively. We used targeted disruption of the 
 
LAMA3
 
 
gene, which encodes the 
 
a
 
3 subunit of laminin 5 and 
other isoforms, to examine developmental functions 
that are regulated by adhesion to the basement mem-
brane (BM). In homozygous null animals, profound ep-
ithelial abnormalities were detected that resulted in 
neonatal lethality, consistent with removal of all 
 
a
 
3-
laminin isoforms from epithelial BMs. Alterations in 
three different cellular functions were identiﬁed. First, 
using a novel tissue adhesion assay, we found that the 
mutant BM could not induce stable adhesion by inte-
grin 
 
a
 
6
 
b
 
4, consistent with the presence of junctional 
blisters and abnormal hemidesmosomes. In the absence 
of laminin 5 function, we were able to detect a new 
ligand for integrin 
 
a
 
3
 
b
 
1 in the epidermal BM, suggest-
ing that basal keratinocytes can utilize integrin 
 
a
 
3
 
b
 
1 to 
interact with an alternative ligand. Second, we identi-
ﬁed a survival defect in mutant epithelial cells that 
could be rescued by exogenous laminin 5, collagen, or 
an antibody against integrin 
 
a
 
6
 
b
 
4, suggesting that sig-
naling through 
 
b
 
1 or 
 
b
 
4 integrins is sufﬁcient for sur-
vival. Third, we detected abnormalities in ameloblast 
differentiation in developing mutant incisors indicating 
that events downstream of adhesion are affected in mu-
tant animals. These results indicate that laminin 5 has 
an important role in regulating tissue organization, 
gene expression, and survival of epithelium.
Key words: laminin 5 • integrins • cell adhesion • epi-
thelial cells • junctional epidermolysis bullosa
 
L
 
AMININS
 
 are multifunctional extracellular matrix (ECM)
 
1
 
proteins that regulate adhesion, motility, gene ex-
pression, and apoptosis. Genetically distinct 
 
a
 
, 
 
b
 
,
and 
 
g
 
 subunits of laminin form specialized heterotrimers
that maintain the function of neuromuscular junctions
(Noakes et al., 1995a), striated muscle (Xu et al., 1994;
Helbling-Leclerc et al., 1995), renal glomeruli (Noakes et
al., 1995b), and skin (Verrando et al., 1987; Carter et al.,
1991; Rousselle et al., 1991). We have focused on skin to
examine regulatory functions in the epidermis mediated
by adhesion to the basement membrane (BM), which led
to the identification of laminin 5 (
 
a
 
3
 
b
 
3
 
g
 
2) as the major ad-
hesive ligand present in the BM of stratified squamous ep-
ithelium (Carter et al., 1991). Laminin 5 differentially reg-
ulates anchorage and motility of epithelial cells through
integrins 
 
a
 
6
 
b
 
4 and 
 
a
 
3
 
b
 
1, respectively (Carter et al., 1990;
Xia et al., 1996; Goldfinger et al., 1998). Proper regulation
of these functions is essential for normal wound repair that
requires keratinocyte activation followed by cell motility
for reepithelialization of the epidermis. Upregulation of
laminin 
 
a
 
3 chain mRNA and protein indicates that newly
synthesized laminin 5 may be required for cell migration
and repair of the BM in vivo (Ryan et al., 1994; Lampe,
1998; Nguyen and Carter, manuscript in preparation).
To investigate the role of laminin 5 in migratory and ho-
meostatic epithelium, we performed targeted ablation of
 
the 
 
LAMA3
 
 gene, which encodes the 
 
a
 
3 subunit of lami-
nin 5. Laminin 5 is expressed in a variety of epithelial tis-
sues (Carter et al., 1991; Aberdam et al., 1994) indicating
that LAMA3 null animals can be used to study multiple
developmental systems. Biochemical studies have identi-
 
fied the 
 
a
 
3 chain as a subunit in laminin 6 (Marinkovich
 
et al., 1992; Gil et al., 1994) and laminin 7 (Champliaud et al.,
1996), suggesting that other laminin trimers derived from
the 
 
LAMA3
 
 gene can be analyzed for loss of function.
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Furthermore, because basal keratinocytes use laminin 5 as
a preferred ligand (Carter et al., 1990), we anticipated that
removal of laminin 5 might allow for the identification of
other BM ligands that could not be detected in the pres-
ence of laminin 5.
In this report, we show that LAMA3 null animals
develop a lethal blistering condition similar to human
junctional epidermolysis bullosa (JEB; Christiano and
Uitto, 1996). Our results demonstrate that ablation of the
 
LAMA3
 
 gene perturbs the formation of hemidesmosomes
(HDs) in homeostatic epithelium and disrupts the func-
tional interaction between laminin 5 and integrin 
 
a
 
6
 
b
 
4.
We found that in the absence of laminin 5 basal cells can
utilize integrin 
 
a
 
3
 
b
 
1 to interact with an alternative BM
ligand. Despite evidence for an alternative 
 
a
 
3
 
b
 
1 ligand
and the presence of multiple laminin isoforms in the BM
of mutant skin, homozygous null animals fail to survive. In
vitro studies indicate that laminin 5 deficient epithelial
cells have a survival disadvantage when compared with
wild-type cells and we identified conditions that will allow
for the rescue of mutant cells. Finally, our data indicate
that events downstream of adhesion are effected in mutant
animals. In particular, we show that ameloblast differenti-
ation is impaired in the developing incisors of mutant ani-
mals. These studies provide a basis to examine the influ-
ence of endogenous and exogenous laminin 5 on cell
survival and gene expression in epithelium. In addition,
because all laminin trimers containing the 
 
a
 
3 chain have
been removed in mutant animals, this animal model has
implications for widespread defects in BM stemming from
the removal of laminins 5–7.
 
Materials and Methods 
 
Materials
 
Restriction enzymes, TaqI polymerase, and RadPrime DNA labeling sys-
tem was purchased from GIBCO BRL. The Biotechnology Core Lab
(Fred Hutchinson Cancer Research Center, Seattle, WA) prepared oligo-
nucleotide primers used for PCR. The multiple tissue Northern blot and
hybridization buffer were purchased from CLONTECH Laboratories,
Inc. FBS was from Summit. Other cell culture reagents included BSA,
trypsin, and hydrocortisone (Sigma Chemical Co.); cholera toxin (Calbio-
chem-Novabiochem Corp.); aminoguanidine (Aldrich Chemical Co.);
EGF (Collaborative Biomedical Products); and keratinocyte growth me-
dium (KGM; Clonetics).
 
Cloning of the Murine LAMA3 Gene
 
A 600-bp cDNA clone (Ep-1) corresponding to the helical region of the
human 
 
a
 
3 laminin chain (Ryan et al., 1994) was used to screen a murine
fetal kidney library. Based on sequence homology, the resulting cDNAs
were confirmed to be the murine equivalent of the 
 
a
 
3-laminin chain. The
clones were later found to be compatible with published sequence for the
murine laminin 
 
a
 
3 chain (Galliano et al., 1995). The 
 
a
 
3 laminin cDNAs
were then used to screen a 129Sv genomic library (kindly provided by Dr.
Phil Soriano, Fred Hutchinson Cancer Center, Seattle, WA) and multiple
clones corresponding to the 
 
LAMA3
 
 gene were identified.
 
Targeted Disruption of the LAMA3 Gene
 
A 1.2-kb NsiI/SacI genomic fragment that contained the murine equiva-
lent of exon A3 from the 
 
LAMA3
 
 gene (Pulkkinen et al., 1998a) was re-
placed with a neo cassette driven by the PGK promoter. The construct
was flanked 5
 
9
 
 and 3
 
9
 
 by a 0.8-kb BglII/NsiI fragment and a 5-kb SacI/SacI
fragment, respectively. Both flanking sequences were derived from ge-
nomic fragments corresponding to the 
 
LAMA3
 
 gene. A PGK-driven
diphtheria toxin expression cassette was placed 5
 
9
 
 to the 0.8-Kb BglII/NsiI
 
fragment. The construct was linearized with XhoI and electroporated into
embryonic stem (ES) cells. Colonies were selected for G418 resistance
and screened for homologous recombination using PCR as described (So-
riano et al., 1991). The PCR strategy included an oligonucleotide from the
 
neo
 
 gene (5
 
9
 
 TCGCAGCGCATCGCCTTCTA 3
 
9
 
) and an oligonucleotide
specific for the 
 
LAMA3
 
 gene (5
 
9
 
 AACCCTGGCTAGTCTGGAAC 3
 
9
 
)
upstream of the 0.8-kb NsiI/BglII fragment used in the targeting construct.
PCR was performed in a DNA Thermal Cycler (Perkin-Elmer Corp.) for
40 cycles as follows: 93
 
8
 
C for 30 s; 55
 
8
 
C for 30 s; 65
 
8
 
C for 3 min. Positive
clones were further characterized by Southern blot analysis using genomic
DNA digested with NsiI and hybridized with an XbaI fragment that is 5
 
9
 
to the PGKneo insert. Tissue culture and blastocyst injections were per-
formed as previously described (Soriano et al., 1991).
 
Histology and Immunohistochemistry
 
For histology, samples were fixed using 10% formalin, rinsed in PBS, de-
hydrated through graded alcohol, and embedded in paraffin. Sections
were stained with hematoxylin and eosin. For immunohistochemistry, fro-
zen tissues were embedded directly in Tissue-Tek O.C.T. Compound
(Sakura Finetek USA, Inc.). Cryostat sections (8–10 microns) were ex-
tracted with 1% Triton in PBS and fixed with 2% formaldehyde in PBS
(20 min). Tissue sections were either stained using a Vectastain ABC kit
(Vector Labs) or processed for immunofluorescence. For the ABC kit,
sections were blocked with 10% goat serum, incubated with primary anti-
body for 2 h, washed, incubated with a biotinylated secondary antibody,
washed, incubated with peroxidase-conjugated avidin, washed, and devel-
oped using diaminobenzidine plus nickel chloride. For immunofluores-
cence, tissue sections were blocked, incubated with primary antibody for 2 h,
washed, incubated with FITC or rhodamine-conjugated secondary anti-
bodies, and washed. Sections were mounted in a solution containing 25
mg/ml of 1,4-diazobicyclo-(2,2,2)octane in glycerol (Johnson et al., 1982)
and visualized for immunofluorescence using a Zeiss Microscope.
 
Electron Microscopy
 
Tissue was fixed with half strength Karnovsky’s fixative plus 0.1% tannic
acid, rinsed in 0.1 M cacodylate buffer, and post-fixed in 2% osmium
tetroxide (Sakai and Keene, 1994). Samples were dehydrated in graded
ethanols and propyleneoxide and then embedded in Polybed 812 resin.
Thin sections (80–90 nm) were cut and stained with uranyl acetate. A
JEOL 100-SX electron microscope was used for examining and photo-
graphing the samples.
 
Culturing of Mouse Epidermal Keratinocytes 
 
Neonatal mouse pups were killed by decapitation, rinsed in 70% ethanol
and PBS, and skinned. The skin was digested in 0.25% trypsin overnight
at 4
 
8
 
C for 14 h. The epidermis was separated from the dermis and placed
in N-medium according to the protocol of Hager et al. (1999). N-medium
is MEM (0.06 mM Ca
 
2
 
1
 
) plus 7.3% chelexed FBS supplemented with cul-
ture supernatant from freshly isolated fibroblasts. N-medium also contains
hydrocortisone, cholera toxin, aminoguanidine, and EGF. Cells are re-
leased from the epidermis into N-medium by shaking. The cells were di-
rectly seeded onto dishes that were untreated or coated with 10 
 
m
 
g/ml of
type IV collagen (Collaborative Biochemical Products; Becton Dickinson
Labware). Immortalized mouse epidermal keratinocytes (MEKs) were
cultured in KGM containing 0.06 mM calcium chloride (Clonetics Corp.).
 
Tissue Adhesion Assays
 
Adhesion assays on tissue sections were as follows: cryostat sections of
split skin from wild-type and mutant animals were attached to the lid of a
petri dish. Tissue sections were washed with PBS and blocked with 0.5%
BSA. Trypsinized human foreskin keratinocytes (HFKs; Carter et al.,
1991) that had been resuspended in KGM (Clonetics Corp.) were labeled
with calcein-AM (Molecular Probes, Inc.) for 15 min at room temperature
(Lampe, 1998). Cells were washed with PBS and incubated with tissue sec-
tions for 1 h in the presence or absence of inhibitory antibodies. After in-
cubation, cells were gently washed once using PBS, fixed with 2% formal-
dehyde in 0.1 M sucrose cacodylate buffer for 20 min, washed three times
in PBS, and rinsed with distilled water. Sections were mounted with a so-
lution containing 25 mg/ml of 1,4-diazobicyclo-(2,2,2)octane in glycerol
(Johnson et al., 1982) and visualized for fluorescence using a Zeiss micro-
scope. 
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Antibodies
 
Rat mAbs against mouse 
 
b
 
1 and 
 
g
 
1 laminin were purchased from Chemi-
con International, Inc. A rat mAb against 
 
b
 
4 integrin was purchased from
PharMingen. Dr. Takashi Hashimoto (Kurume University, Kurume,
Fukuoka, Japan) kindly supplied human mAb 5E against bullous pemphi-
goid antigen 230 (BP230; Hashimoto et al., 1993). Dr. Eva Engvall (Burn-
ham Institute, La Jolla, CA) provided polyclonal antibodies for 
 
a
 
1 and 
 
a
 
2
laminin chains, which were made against the E3 fragment of EHS laminin
and recombinant domain VI from the 
 
a
 
2 chain, respectively. A polyclonal
antibody prepared against recombinant 
 
a
 
5 laminin was prepared by Dr.
Jeffery Miner (Washington University, St. Louis, MO) as previously de-
scribed (Miner et al., 1997). A polyclonal antiserum that was prepared
against laminin 5 isolated from rat 804G cells was supplied by Dr. Jona-
thon Jones (Northwestern University, Chicago, IL; Langhofer et al.,
1993). A mouse mAb, D3-4, that cross-reacts with mouse laminin 5 was
prepared in this lab by Susana Gil as previously described (Gil et al.,
1994). Secondary antibodies were purchased from Vector Labs, Southern
Biotechnology Associates Inc., and Jackson ImmunoResearch Laborato-
ries, Inc.
 
Results
 
Analysis and Strategy for Targeted Disruption of the 
LAMA3 Gene
 
Northern blot analysis showed that two major transcripts
for the laminin 
 
a
 
3 chain are expressed in multiple mouse
tissues (Fig. 1). The schematic illustration in Fig. 1 indi-
cates that multiple laminin trimers can be derived from
these gene products. Therefore, to introduce a mutation
into the 
 
LAMA3
 
 gene, we developed a strategy that would
ablate all possible 
 
a
 
3-laminin trimers. We removed the
murine equivalent of exon A3 of the 
 
LAMA3
 
 gene (Pulk-
kinen et al., 1998a) and flanking sequence from the 5
 
9
 
 NsiI
site (Ns*) to the 3
 
9
 
 SacI site (S*) replacing it with a PGK-
driven neomycin (
 
neo
 
) cassette (Fig. 2 A). The coding se-
quence of exon A3 is common to both the 
 
a
 
3a and 
 
a
 
3b
transcripts (Ryan et al., 1994). Consequently, removal of
exon A3 will cause a frame shift mutation followed by a
premature stop codon that will disrupt the 
 
a
 
3a and 
 
a
 
3b
transcripts produced by the 
 
LAMA3
 
 gene (Ryan et al.,
1994).
The targeting construct (Fig. 2 A) was introduced into
129Sv ES cells by electroporation and homologous recom-
bination occurred at a frequency of 12%. Southern blot
analysis on genomic DNA digested with NsiI confirmed
the presence of the mutant allele (Fig. 2 B). Five clones
that contained the mutant allele were used for blastocyst
injection resulting in the generation of multiple chimeric
animals. Chimeric animals generated from ES clones 5-2,
15-4, and 19-1 (Fig. 2 B) were crossed with C57BL/6J fe-
males. ES-agouti coat color identified pups with germline
transmission of the mutant gene. Mice heterozygous for
the 
 
LAMA3
 
 mutation were crossed to obtain homozygous
null offspring. Homozygous null animals derived from ES
clones 5-2, 15-4, and 19-1 displayed similar phenotypes, so
we continued our studies with the animals generated from
ES clone 5-2. PCR analysis was used to determine the ge-
notype of the offspring by using primers designed to detect
the wild-type and mutant alleles (Fig. 2 C).
 
Phenotype of LAMA3 Null Mice
 
Homozygous 
 
a
 
3
 
2
 
/
 
2
 
 null animals appeared indistinguish-
able from 
 
a
 
3
 
1
 
/
 
2
 
 and 
 
a
 
3
 
1
 
/
 
1
 
 wild-type littermates at birth
(Fig. 3 A). After birth, homozygous 
 
a
 
3
 
2
 
/
 
2
 
 null animals,
referred to as mutant animals, develop progressive blister-
ing of the forepaws, limbs, and oral mucosa (Fig. 3, B and
E). 25% of the newborn pups were homozygous null, sug-
gesting that failure to express 
 
a
 
3 did not cause embryonic
lethality in the C57BL/6J genetic background. However,
the animal in Fig. 3 C showed more extensive blistering
than most of the mutant littermates, suggesting that the
skin phenotype may be more severe in some of the af-
fected animals. In most cases, the limbs and paws of the
Figure 1. Transcripts produced
by the LAMA3 gene. A North-
ern blot containing polyA1
RNA from adult mouse tissues
was hybridized with a probe
overlapping with the a-helical
domain of the a3a and a3b tran-
scripts. Brain and lung express
10- and 6-kb transcripts, while
liver and kidney express prima-
rily the 6-kb transcript. Expres-
sion of a3-laminin mRNA was
not detectable in adult mouse
spleen, skeletal muscle, or tes-
tes. A faint signal for the 10-kb
transcript was present in heart.
The 10-kb transcript corre-
sponds to a full-length a3b
polypeptide chain (Ryan et al.,
1996; Doliana et al., 1997; Miner
et al., 1997) while the 6-kb tran-
script is expressed as a truncated a3a chain, lacking the NH2-terminal protein domains (Ryan et al., 1994). Extended arrows point to
possible laminin trimers synthesized from full-length and truncated a3 chains. Removal of exon A3 (Fig. 2) will ablate the a3-laminin
chain at the start of the helical region (short arrow) preventing the assembly of laminin 5 and other laminin isoforms. Trimers for lami-
nin 5 and 6 have been identified (Carter et al., 1991; Marinkovich et al., 1992; Gil et al., 1994). The composition of trimers derived from
the full-length a3b chain has not been characterized, so the proposed structure is indicated as laminin X.The Journal of Cell Biology, Volume 145, 1999 1312
mutant animals were visibly red and bleeding (Fig. 3 F),
even when blistering lesions were not detected. It was
noted that the content of the mutant stomach was substan-
tially smaller (Fig. 3 D) and the mutant animals weighed
40–50% less than wild-type littermates. The presence of
milk in the intestine of mutant animals indicates that there
was no gastric obstruction, such as pyloric atresia, which
can occur in JEB patients with mutations in integrin a6b4
(Vidal et al., 1995; Brown et al., 1996). The mutant animals
died 2–3 d after birth from a failure to thrive, possibly
caused by dehydration and malnutrition.
Paraffin-embedded sections of skin from wild-type and
mutant animals were analyzed using hematoxylin and eo-
sin staining (Fig. 4, A–C). The lesions present in mutant
skin were confirmed to be junctional blisters caused by a
separation at the dermal–epidermal junction (Fig. 4 C).
The epidermis of mutant skin showed distinct organiza-
tional changes in lesional areas when compared with non-
lesional areas. In lesional areas, the epidermis contained
clusters of cells in the superbasal layer that maintained an
undifferentiated morphology (Fig. 4 C) similar to the pearl
cells described in b4 null animals (Dowling et al., 1996). It
was noted that the basal cells present in lesional regions
were sparse and contained flattened nuclei (Fig. 4 C).
These alterations contrasted with the organization of the
epidermis in nonlesional regions. In nonlesional regions of
mutant skin (Fig. 4 B), the morphology of the basal cells
and the organization of the epidermis were similar to that
of the wild-type skin (Fig. 4 A).
Laminin Expression in Wild-type and Mutant Skin
Immunostaining confirmed the absence of laminin 5 from
the epidermal BM of mutant skin (Fig. 4 E), consistent
with the blistering phenotype. Using mAb D3-4, we
sought to examine the expression of all a3-laminin het-
erotrimers in skin. mAb D3-4 immunoprecipitates multi-
ple  a3-containing heterotrimers from human keratino-
cytes (Gil et al., 1994), including laminin 5 (a3b3g2) and
laminin 6 (a3b1g1), suggesting that it interacts with a3
chain. Immunostaining showed that mAb D3-4 was posi-
tive in wild-type skin, but absent from the epidermal BM
of mutant skin (Fig. 4, F and G). The absence of staining in
the mutant BM with mAb D3-4 (Fig. 4 G) shows that we
Figure 2. (A) Strategy for ho-
mologous recombination. Exon
A3 of the murine LAMA3 gene
and flanking sequence from the
59 NsiI site (Ns*) to the 39 SacI
site (S*) were replaced by a neo-
mycin (neo) cassette. The re-
moval of exon A3 will cause a
frameshift resulting in a prema-
ture stop codon that will disrupt
the a3a and a3b transcripts of
the LAMA3 gene. (B) Southern
blot of ES cells. Genomic DNA
from wild-type (control) and re-
combinant (ES 5-2, 15-4, and
19-1) ES cells was isolated and
digested with NsiI. The wild-
type ES cells (control lane) con-
tain only a 3.5-kb NsiI fragment
corresponding to the normal
LAMA3 gene. In contrast, the
recombinant ES cells contain an
additional 4.4-kb NsiI fragment,
which corresponds to the mu-
tated LAMA3 gene (ES 5-2,
15-4, and 19-1 lanes). (C) PCR
analysis of wild-type and mutant
pups. Primers designed to detect
the wild-type and mutant alleles
were used to genotype the wild-
type and affected littermates.
The affected animals were ho-
mozygous for the mutant allele
(a32/a32, lanes 2 and 3) while
the unaffected littermates were
either homozygous (a31/a31,
lane 1) or heterozygous (a31/
a32, lane 4) for the wild-type
allele. Genomic DNA from het-
erozygous ES cells was used as a
control (ES 5-2, lane 5).Ryan et al. Targeted Disruption of the LAMA3 Gene 1313
have removed all laminin trimers containing the a3 chain
from the BM of mutant skin. We also found that a3-lami-
nin was absent from multiple tissues in late stage mutant
embryos including the tissues that were shown by North-
ern blot analysis to express the a3a and a3b transcripts
(data not shown). In contrast, immunostaining showed
that the expression of the b1 and g1 laminin chains were
maintained in the wild-type and mutant tissues (Table I).
The b1 and g1 subunits of laminin form trimers with dif-
ferent a chains to generate tissue-specific laminin isoforms
(Engvall et al., 1990; Miner et al., 1997). Therefore, we
used antibodies against the a1-, a2-, and a5-laminin chains
to identify which laminin isoforms are present in the epi-
dermal BM of wild-type and mutant skin. Strong staining
for a5 laminin is maintained in wild-type (Fig. 4 H) and
mutant (Fig. 4 I) skin, indicating that laminin 10 (a5b1g1)
or 11 (a5b2g1) may be present in the epidermal BM. The
results, summarized in Table I, indicate that multiple lami-
nin isoforms remain in the BM of mutant skin. However,
none of the other laminins are sufficient to stabilize the
adhesion of epithelium to the BM.
Structure and Composition of HDs
The skin phenotype of mutant animals is consistent with
an autosomal recessive disorder in humans known as
junctional epidermolysis bullosa-gravis (JEB-G; Christi-
ano and Uitto, 1996). The loss of anchorage function in
mutant epidermis led us to examine the organization and
composition of HDs in mutant skin. HDs link the laminin
5-rich BM to the keratin cytoskeletal through integrin
a6b4 (Carter et al., 1990; Stepp et al., 1990). BP230 stabi-
lizes the adhesion plaque on the cytoplasmic side (Tanaka
et al., 1991). Immunohistochemical staining showed that
integrin a6b4 and BP230 are expressed and are polarized
in the basal cells of wild-type (Fig. 5, A and B) and mutant
(Fig. 5, C and D) skin. Integrin a6b4 and BP230 both
displayed an unexpected discontinuous organization in
blistered and nonblistered regions of mutant skin when
compared with the wild-type (Fig. 5, E and F). This discon-
Figure 3. Phenotype of the
null animals. (A) Newborn
mutant (a32/2) and wild-
type (a31/1) pups before
blister formation. Arrow indi-
cates reduced milk content in
the stomach of the mutant
pup. (B) Progression of the
phenotype in an affected pup
48 h after birth. Blistering of
the forelimbs and oral mu-
cosa is shown. (C) A 48 h mu-
tant pup with severe blister-
ing showing loss of epidermis
over a significant percentage
of the head and body. (D)
Milk in the gastrointestinal
tract of the wild-type (a31/1)
and mutant (a32/2) pup
indicates that there is not
an obstruction between the
stomach and intestine (py-
loric atresia) in mutant pups.
The reduced stomach size
and milk content was consis-
tently observed in mutant
pups. (E) Front paw of a mu-
tant pup in the early stages of
blistering, z6–8 h after birth.
The digits of the forelimbs
are not detectable because
the epidermis has formed a
cuff over the paw. (F) Bleed-
ing, indicated by the arrow,
was frequently detected in
the forelimbs of the mutant
animals, even when blister-
ing was not detectable.
Table I. Laminin Expression in Mouse Skin
Laminin chain Normal Mutant
b1 11
g1 11
a1 11
a2 1 (weak) 1 (weak)
a3 12
a5 11The Journal of Cell Biology, Volume 145, 1999 1314
tron dense plaque (Fig. 6, A and B). Anchoring filaments
extend from the basal lamina toward the HD. In the cyto-
plasm, keratin filaments accumulate near the subbasal
plaque (Fig. 6 B). This fine structural organization was
lacking in mutant animals. The epidermis of mutant skin
contained electron dense plaques at the plasma mem-
brane, but lacked discernible subbasal plaques (Fig. 6, C
and D). Intermittently, rudimentary HDs formed at the
plasma membrane in the mutant animals (Fig. 6 D). Con-
Figure 4. Junctional blisters
and laminin expression in
mutant skin. Normal (A) and
mutant (B and C) skin was
fixed in 4% formalin, paraf-
fin embedded, and sections
were stained with hematoxy-
lin and eosin. (C) A junc-
tional blister present in the
mutant skin that is character-
ized by a separation of the
epidermis (e) from the der-
mis (d) at the BMZ. Basal
cells in the lesion appear
sparse and flattened (ar-
rows). Arrows with asterisks
mark cell clusters that appear
undifferentiated in the super-
basal cell layer (C). Cyrostat
sections of OCT-embedded
skin sections from normal
(D, F, and H) and mutant
skin (E, G, and I) were ex-
tracted with 1% Triton X-100,
fixed with 2% formaldehyde,
and immunostained with an
antilaminin 5 polyclonal anti-
body (D and E), anti-a3
laminin mAb (F and G), and
anti-a5 laminin polyclonal
antibody (H and I). D and E
were immunostained using
peroxidase-conjugated  sec-
ondary antibodies, whereas
F–I were visualized using ei-
ther FITC- or rhodamine-
conjugated secondary anti-
bodies. The BMZ is marked
with arrows. The absence of
staining for laminin 5 (E) or
a3-laminin (G) shows that all
laminin trimers containing
the  a3 chain have been re-
moved from the BMZ of mu-
tant skin. As expected, nor-
mal skin is positive for
laminin 5 (D) and the a3
subunit of laminin 5 and 6
(F). Expression of a5-lami-
nin trimers are present in
normal (H) and mutant
skin  (I).
tinuity suggests that the absence of laminin 5 effects orga-
nization of HD components in basal cells, even in nonle-
sional areas. Furthermore, these results identify a novel
phenotypic alteration in HDs that may be diagnostic in
cell adhesion defects stemming from abnormalities in the
basement membrane zone (BMZ).
We used transmission electron microscopy to examine
the ultrastructure of HDs in tissue. HDs appear normal in
wild-type animals, containing a basal and subbasal elec-Ryan et al. Targeted Disruption of the LAMA3 Gene 1315
sistent with our immunostaining results, there was discon-
tinuity in the formation of electron dense plaques resulting
in a complete absence of HDs in some regions of the basal
cells in mutant skin (Fig. 6 D). Taken together, these find-
ings indicate that the formation and stability of continuous
HDs at the basal surface requires laminin 5, whereas basal
polarization of integrin a6b4 and BP230 proceed in the
absence of laminin 5.
Detection of a Ligand for Integrin a3b1
To evaluate the adhesive properties of the BM in vivo,
short term adhesion assays were done on cryostat sections
of split skin from wild-type and mutant animals (Gil, S.G.,
T.A. Brown, and W.G. Carter, manuscript in preparation).
Previous studies have indicated that the function of b4 in-
tegrin can be more effectively evaluated when the function
of b1 integrins are suppressed (Niessen et al., 1994; Xia et
al., 1996). Therefore, we used cytochalasin D to suppress
the function of b1 integrins by inhibiting the organization
of the actin cytoskeleton, which allowed the function of
b1 and b4 integrins to be distinguished. Tissue adhesion
assays were done using human foreskin keratinocytes
(HFKs) instead of mouse keratinocytes because some of
the inhibitory antibodies do not cross-react with mouse
cells. Fig. 7 A shows that HFKs adhere well to the BM of
wild-type tissue regardless of whether they are untreated
(Fig. 7 A, a) or pretreated with cytochalasin D (Fig. 7
A, b). The cytochalasin D-resistant adhesion could be
blocked using an inhibitory antibody against a6 integrin
(Fig. 7 A, c) indicating that this interaction is dependent
on integrin a6b4. In contrast, pretreatment of HFKs with
cytochalasin D resulted in complete inhibition of adhesion
to the BM of mutant tissue (Fig. 7 A, h) demonstrating the
loss of a functional interaction between integrin a6b4 and
laminin 5. However, in untreated HFKs, we were able to
detect adhesion to the mutant BM (Fig. 7 A, g), suggesting
that a ligand for b1 integrin is present in the BM of mutant
tissue. This led us to investigate which b1-integrin receptor
was required for adhesion to the mutant BM. The results
showed that mAb P1B5, an inhibitory antibody against in-
tegrin a3, significantly reduced adhesion to the BM of mu-
tant tissue (Fig. 7 B, h) when compared with the control
(Fig. 7 A, g). A comparison of several representative areas
indicated that the inhibition observed in the presence of
P1B5 was z80%. A combination of anti-a3 and anti-a6 in-
hibitory antibodies allowed for complete inhibition of ad-
hesion to the BM of mutant skin (Fig. 7 B, i). The nature
of any contribution from integrin a6, if significant, awaits
further investigation. It is sufficient that in the presence of
mAb P1B5 adhesion of HFKs to the mutant BM is re-
duced by .80% demonstrating that a ligand for integrin
a3b1 is detectable in laminin 5 deficient tissue. In contrast,
mAb P1B5 (Fig. 7 B, b) did not effect adhesion of HFKs to
the wild-type BM due to the interaction of laminin 5 with
integrin a6b4. This was confirmed by using a combination
of GoH3 and P1B5, which completely blocked adhesion of
HFKs to the wild-type tissue (Fig. 7 B, c). Therefore, in
mutant tissue, we were able to detect a ligand for integrin
a3b1 that could not be detected in wild-type tissue be-
cause of the dominant interaction of laminin 5 with inte-
grin a3b1 and integrin a6b4. These results provide evi-
dence that other endogenous BM proteins can serve as a
ligand for a3b1, but not for the anchorage function medi-
ated by integrin a6b4 in the epidermis.
Reduced Survival of Laminin 5 Deficient Keratinocytes
MEKs were isolated from wild-type and mutant skin. The
yield of cells and seeding density was comparable for nor-
mal and mutant MEKs. However, in contrast to normal
MEKs, mutant MEKs failed to survive when plated on an
untreated culture dish (Fig. 8, compare A and B). Survival
of mutant MEKs was restored when cells were plated on
an exogenous ligand such as collagen (Fig. 8, compare B
and D). These results show that ablation of laminin 5 is
sufficient to prevent the survival of mutant MEKs in the
absence of an exogenous ligand. This concept was further
reinforced with the generation of a laminin 5 deficient cell
line. Using the E6/E7 transforming genes from papilloma
virus (Kaur et al., 1989) we immortalized wild-type and
mutant epithelial cells. The mutant epithelial cells re-
mained dependent on exogenous ligand for survival and
this dependence was confirmed in a growth curve (Fig. 9).
Using flow cytometry, there was no accumulation of a pre-
G1 peak (Dou et al., 1995), suggesting that extensive
Figure 5. Expression of HD components in normal and mutant
skin. Cyrostat sections of OCT-embedded skin sections from nor-
mal (A and B) and mutant skin (C–F) were extracted with 1%
Triton X-100, fixed with 2% formaldehyde, and immunostained
with anti-integrin b4 (A, C, and E) or anti-BP230 (B, D, and F).
E and F are higher magnification views of the boxed region in C
and D to show the discontinuous expression of integrin b4 (E)
and BP230 (F) in mutant skin.The Journal of Cell Biology, Volume 145, 1999 1316
apoptosis was not occurring in the mutant cells (data not
shown). Studies were initiated to identify receptor/ligand
interactions that could rescue the survival defect in mutant
MEKs. Laminin 5-enriched ECM (Fig. 8, compare F and
H) or immobilized anti-integrin b4 antibody (Fig. 8, com-
pare F and J) were able to rescue mutant MEKs, suggest-
ing that interactions of laminin 5 with integrin a6b4
contribute to the survival of epithelial cells. Because kera-
tinocytes use integrin a3b1 and a6b4 to interact with lami-
nin 5, both receptors may be contributing to the enhanced
survival observed on laminin 5 (Fig. 8, compare F and H).
We could not evaluate the contribution from integrin
a3b1 separately because antibodies that react with mouse
are not available. However, rescue of mutant MEKs on
collagen (Fig. 9) or immobilized anti-a2 antibody (data
not shown) indicate that ligation of b1 integrins is also suf-
ficient to rescue survival of mutant MEKs. In contrast to
mutant cells, the MEKs derived from normal animals re-
tained a high survival rate and characteristic epithelial
morphology regardless of whether they were plated on un-
treated culture dishes, exogenous ligand, or immobilized
antibody (Fig. 8 E, G, I, and Fig. 9). Therefore, within the
limits of this assay, we found that ligation of b1 or b4 inte-
grins are sufficient to rescue the survival defect resulting
from ablation of laminin 5. These results confirm the pro-
posal that laminin 5 secreted into the ECM by cultured ke-
ratinocytes is the primary adhesive ligand produced by
these cells, even though an additional ligand for integrin
a3b1 resides in the BM.
Ameloblast Differentiation Is Dependent on Laminin 5
Laminin 5 is expressed in a variety of epithelial BMs. In
skin, we observed severe defects in basal keratinocytes re-
sulting in abnormal HDs and loss of anchorage function in
the BM of the mutant epidermis. We predicted that if
laminin 5 were involved in late stage differentiation we
would be able to detect abnormalities in other target or-
gans that develop late in gestation. Examination of cross-
sections from neonatal mice revealed gross abnormalities
in the developing incisors of mutant animals. Therefore,
developing incisors of wild-type and mutant animals were
selected for further investigation. Cross-sections from me-
dial to lateral regions of the head were taken to evaluate
histogenesis of the incisors at different stages of matura-
tion (Fig. 10 A). Progressive differentiation is identifiable
from the base of the tooth (region I) to the tip (region III
and VI). The stages of differentiation are outlined for
ameloblasts (Fig. 10, B and C), which are the specialized
epithelial population that deposit enamel on one side of
Figure 6. Electron micro-
graph of wild-type and mu-
tant skin. A and B show the
ultrastructure of wild-type
mouse skin. (A) HDs (hd)
are clearly defined in the
wild-type mouse skin. (B)
Higher magnification shows
the outer and inner electron
dense plaque of the HDs (hd)
with keratin filaments (k)
running toward the HDs. Be-
neath the HDs is the BMZ,
which contains laminin 5.
The mutant skin (C and D)
contains rudimentary HDs
(rhd) that are not well-
defined. Higher magnifica-
tion (inset in D) shows that
the HDs in the mutant skin
are more diffuse and less
well-defined.Ryan et al. Targeted Disruption of the LAMA3 Gene 1317
the developing rodent incisor (Fig. 10 C, a). Mitotic pre-
ameloblasts of the inner dental epithelium located at the
base of the tooth in region I (Fig. 10, B and C) develop
into post-mitotic, secretory ameloblasts in region II (Fig.
10, B and C) and produce the enamel layer of the tooth. A
sharp boundary is visible at the junction between the
ameloblasts and the stratum intermedium (Fig. 10 F,
boundary between a and si). This boundary corresponds to
cytoplasmic filaments, not a BM. The BM is located be-
tween the developing tooth and the ameloblast (Fig. 10 F,
bm). As a result, the nuclei of the ameloblast become po-
larized away from the BM (Fig. 10 G). Consistently, im-
munostaining with mAb D3-4 showed intense deposition
of the laminin a3 chain between the secretory ameloblasts
and the enamel boundary in the wild-type incisor (Fig. 10
D). Positive staining with mAb D3-4 was absent from a
comparable region of the mutant tooth (Fig. 10 E) con-
firming the removal of laminin a3 chain trimers from the
developing incisor.
Cross-sections from comparable regions of the wild-type
teeth (Fig. 10, F–I and N) and mutant teeth (Fig. 10, J–M
and O) were evaluated. In wild-type incisors, secretory
ameloblasts of region II were discernible as elongated epi-
thelial cells with Tomes’ processes extending toward the
deposited enamel (Fig. 10 G). Differentiation continued
normally with the appearance of ruffled edge mature
ameloblasts in region III (Fig. 10 H) followed by the for-
mation of the reduced enamel epithelium in region IV
Figure 7. Tissue adhesion assay. Cryostat sections containing split skin from wild-type (a–f) and mutant (g–l) animals were incubated
with normal HFKs that previously had been labeled with fluorescent dye. (A) Normal HFKs were either untreated (control) or pre-
treated with cytochalasin D (cyto D) and incubated with wild-type (a–f) or mutant (g–i) skin sections in the absence or presence of
GoH3 as indicated. Fluorescent images for normal (a–c) and mutant (g–l) split skin are shown above the corresponding phase-contrast
photo (d–f, j–l). Phase-contrast photos contain the dermis and BMZ. The epidermis has been separated from the BMZ and is not visible
in most photos. Labeled HFKs are adherent to the BM of wild-type split skin in the untreated control (a) and cytochalasin D treated
samples (b), but not in samples treated with a combination of cytochalasin D 1 GoH3 (c). Incubation of mutant split skin with HFKs
shows that only untreated HFKs can bind (g). Pretreatment with cytochalasin D was sufficient to inhibit adhesion to the mutant BM, re-
gardless of whether the assay was done in the absence (h) or presence (i) of GoH3. (B) Labeled HFKs were incubated with wild-type
split skin (a–f) or mutant split skin (g–l) in the absence of inhibitory antibodies (a, d, g, and j), in the presence of P1B5 (b, e, h, and k), or
in the presence of P1B5 1 GoH3 (c, f, i, and l). Adhesion of HFKs to the BM of wild-type split skin is detectable in the absence (a and
d) or presence (b and e) of P1B5, but not in the presence of P1B5 1 GoH3 (c and f). Adhesion of HFKs to mutant BM can be inhibited
with P1B5 alone (h and k) or with P1B5 1 GoH3 (i and j). In the control, HFKs adhere well to the mutant BM in the absence of inhibi-
tory antibodies (g and j). The phase-contrast photos for normal (d and e) and mutant (j) tissue shows that cell adhesion is to the BM.The Journal of Cell Biology, Volume 145, 1999 1318
(Fig. 10, I and N). A discrete morphological change occurs
in region IV: the stratum intermedium no longer marks a
discrete boundary (Fig. 10 N, arrow) because the amelo-
blasts, stratum intermedium, stellate reticulum, and outer
dental epithelium become incorporated into the stratified
epithelium referred to as the reduced enamel epithelium.
In mutant animals, incisor development appeared nor-
mal until the onset of enamel secretion. Presecretory
ameloblasts in region I of wild-type (Fig. 10 F) and mutant
animals (Fig. 10 J) are indistinguishable. At the onset of
enamel secretion in region II, the ameloblasts of mutant
incisors (Fig. 10 K) were shorter with visible undulations
at the edges when compared with wild-type incisors (Fig.
10 G). As differentiation proceeded, the ameloblasts of
the mutant incisor continued to be reduced in size relative
to the wild-type teeth (Fig. 10, H and L; compare height of
ameloblasts relative to double arrows in H and L) and
enamel deposition did not appear normal. The enamel
edge of mutant incisors appeared frayed in comparison to
the enamel deposited in wild-type incisors (Fig. 10, com-
pare H and L). The abnormal appearance and size of the
mutant ameloblasts made it difficult to distinguish the
transition from secretory ameloblasts of region II to ma-
ture ameloblasts of region III. In region IV, where the
ameloblasts and the adjacent stratum intermedium form
the reduced enamel epithelium, tissue organization was
completely disrupted (Fig. 10, compare N to O). This dis-
organization corresponded precisely with the point where
the stratum intermedium no longer formed a discrete
boundary (Fig. 10 O, arrow). At this junction between re-
gion III and IV the reduced enamel epithelium should
form a stratified epithelium. This does not occur in the
mutant tissue (Fig. 10 O). These results define a role for
Figure 8. Survival of primary and immortalized mouse epithelial cells. Primary MEKs isolated from wild-type (A and C) and mutant (B
and D) skin were plated on untreated tissue culture (TC) dishes (A and B) or dishes coated with 10 mg/ml of collagen type IV (Col; C
and D). Mutant MEKs were unable to survive on untreated TC dishes (B), but could be rescued by plating on collagen (D). Immortal-
ized MEKs derived from wild-type (E, G, and I) or mutant epithelial cells (F, H, and J) were plated on untreated TC dishes (E and F),
laminin 5-enriched ECM (G and H), or immobilized anti-b4 antibody (I and J). The mutant MEKs did not grow on untreated TC dishes
(F), but could be rescued on ECM (H) or immobilized anti-b4 antibodies (J). MEKs derived from wild-type animals survived indepen-
dent of exogenous ligand (compare E, G, and I).
Figure 9. Growth curve of
epithelial cells. Laminin
5-expressing and laminin 5
deficient epithelial cell lines
were grown in KGM (60 mM
Ca21) on either collagen (10
mg/ml) or untreated tissue
culture dishes. Laminin
5-expressing cells grew on
collagen (filled squares) and
untreated tissue culture
dishes (open diamonds).
Laminin 5 deficient cells
failed to grow on untreated
tissue culture dishes (filled
diamonds), but could be res-
cued by plating on collagen
(open squares).Ryan et al. Targeted Disruption of the LAMA3 Gene 1319
the a3 subunit of laminin 5 in murine tooth development
and provide a biological basis for the hypoplastic enamel
that has been described in human JEB-G (Wright et al.,
1993).
Discussion
Laminin 5 Regulates the Organization of HDs
Our results show that loss of a6b4-laminin 5 anchorage
Figure 10. Analysis of devel-
oping incisors. Neonatal pups
were killed by decapitation,
heads were cut at the mid-
line, fixed in 10% formalin,
and processed for paraffin
embedding. (A) Cross-sec-
tions were taken from medial
to lateral regions of the head.
Cartoon (B) and hematoxy-
lin- and eosin-stained section
(C) show the progression of
differentiation occurring in
the inner dental epithelium
from the base of the tooth
(region I) to the tip (re-
gion III and VI). Mitotic
preameloblasts of the inner
dental epithelium present in
the base of region I develop
into post-mitotic, secretory
ameloblasts in region II and
produce the enamel layer of
the tooth. A single layer of
cells, referred to as the stra-
tum intermedium (si), is adja-
cent to the ameloblasts (a).
The discrete line visible be-
tween the stratum interme-
dium and the ameloblasts is
not BM. The BM is located
between the tooth and the
differentiating ameloblasts
(see F and G). During
enamel secretion (region II),
the BM is absent, but it re-
forms during ameloblast mat-
uration (region III and IV).
Immunostaining with mAb
D3-4 shows that the laminin
a3 chain is expressed during
ameloblast differentiation in
the wild-type (D), but not the
mutant (E) tooth. Cross-sec-
tions from comparable re-
gions of wild-type (F–I and
N) and mutant (J–M and O)
teeth are shown for region I
(F and J), region II (G and
K), region III (H and L), and
region IV (I and M). The
double arrows in H and L are
the same size to emphasize
the reduced size of the mu-
tant ameloblasts. N and O
are enlargements of I and M,
respectively. The white arrow
marks the location where the boundary between the stratum intermedium and the ameloblasts is no longer distinguishable. At this pre-
cise location, the organization of the mutant epithelium becomes extremely disorganized (compare N and O). Abbreviations are as fol-
lows: a, ameloblasts; o, odonoblasts; bm, basement membrane; si, stratum intermedium; e, enamel; ree, reduced enamel epithelium. The
cartoon in B was modified from Eisenmann (1989).The Journal of Cell Biology, Volume 145, 1999 1320
functions have profound effects on HD organization. Dis-
continuities in localization of integrin a6b4 and BP230
were so prominent in mutant tissue that they could easily
be detected at the light microscope level by immunohis-
tochemical staining with anti-b4, -a6, or -BP230 antibod-
ies. Analysis with other cellular markers, such as keratin-1
or keratin-14, did not display alterations that would allow
us to distinguish between wild-type and mutant skin (data
not shown). In contrast, the discontinuous staining of a6b4
and BP230 was reproducible in 100% of the homozygous
null pups allowing us to readily identify wild-type and mu-
tant skin. Because the discontinuity of b4-integrin and
BP230 staining occurred in both lesional and nonlesional
regions, our data suggests that HD alterations are a pri-
mary consequence of laminin 5 deficiency rather than a
secondary effect caused by the lesion. Consistently, a sub-
population of patients lacking either laminin 5 or bullous
pemphigoid antigen 180 (BP180) display a similar disorga-
nization of HD proteins (Brown, T.A., and W.G. Carter,
unpublished observation), suggesting that this phenotypic
alteration may have diagnostic value in patients with struc-
tural abnormalities in the BMZ. It was noteworthy that
the discontinuity of a6b4 and BP230 appeared to occur at
cell–cell boundaries, suggesting that stability of cell–cell
junctions may be reduced in these regions. The notion that
cell-substrate adhesion can regulate interactions at cell–
cell junctions has been established in epithelial cells.
Tiam1/Rac signaling in epithelial cells can promote either
cell–cell adhesion or cell migration depending on the type
of matrix used for cell adhesion (Sander et al., 1998). Simi-
larly, laminin 5 interactions with integrin a3b1 selectively
promote intercellular communication of basal keratino-
cytes through gap junctions (Lampe, 1998).
Ablation of LAMA3 Results in JEB and
Survival Defects
Ablation of the LAMA3 gene causes a phenotype similar
to a lethal variant of human epidermolysis bullosa, JEB-G.
Clinical features of JEB-G include mechanical fragility of
the skin, growth retardation, oral erosions, gastrointestinal
and genitourinary tract involvement, dental abnormalities,
hypoplastic HDs, and high morbidity (Fine et al., 1991).
JEB-G is an autosomal recessive disorder that has been
associated with mutations in the LAMA3 (Kivirikko et al.,
1995),  LAMB3 (Pulkkinen et al., 1994b), and LAMC2
(Pulkkinen et al., 1994a) genes of laminin 5. Mutations in
the LAMA3 gene have been documented in only a small
fraction of the JEB-G cases, which led us to wonder if null
mutations in the LAMA3 gene would result in embryonic
lethality, particularly since we removed all trimers con-
taining the a3 chain from the BM, including laminins 5–7.
On the contrary, we found that mice homozygous for the
null mutation were born at the expected frequency of
25%, suggesting that embryonic lethality did not occur in
the C57/BL6 genetic background. The reduced number of
patients with mutations in the LAMA3 gene relative to the
other genes that encode laminin 5 may be due in part to a
reported hotspot in the LAMB3 gene (Kivirikko et al.,
1996).
In vitro studies on primary and immortalized kerati-
nocytes (Figs. 8 and 9) have indicated that laminin 5 con-
tributes to keratinocyte survival, which may have rele-
vance to pathology of human JEB-G. Jonkman et al.
(1997) described an individual who is mosaic for mutations
in the COL17A1 gene encoding BP180, a component of
HDs. Surprisingly, the subpopulation of keratinocytes
from this mosaic individual that express BP180 display a
survival advantage in culture and in the skin of the individ-
ual (Jonkman et al., 1997). Thus, both laminin 5 and
BP180 provide a survival advantage for keratinocytes. Cu-
riously, keratinocytes from individuals with JEB-pyloric
atresia with inherited defects in b4 appear to survive in
culture as well as or better than wild-type keratinocytes
(Gil and Carter, unpublished observation). Additional ex-
periments will be necessary to determine if the survival ad-
vantage observed in wild-type cells is due to a direct effect
of laminin 5 on cell cycle regulation through integrins. It
has been shown that adhesion of primary keratinocytes to
laminin 5 promotes entry into the cell cycle through signal-
ing pathways that are generated by ligation of integrin
a6b4 (Mainiero et al., 1997; Murgia et al., 1998). Laminin
5 may also promote cell proliferation through a second sig-
naling pathway involving integrin a3b1 (Gonzales et al.,
1999). Consistently, our results indicate that exogenous
ligands are not adequate for longterm survival of mutant
MEKs (Ryan, M.C., unpublished observation), suggesting
that the survival contributions from laminin 5 may not
simply be due to adhesion. Whether or not exogenous
laminin 5 is sufficient to rescue defective cellular functions
caused by the absence of endogenous laminin 5 remains to
be determined, particularly since endogenous and exoge-
nous laminin 5 may have different biological functions.
Exogenous laminin 5 is a scatter factor for carcinoma cells
that do not make endogenous laminin 5, but not for carci-
nomas that deposit endogenous laminin 5 (Kikkawa et al.,
1994). Similarly, we have observed that keratinocytes from
JEB-G patients with defective laminin 5 expression and
MEKs from LAMA3 null animals will both scatter in re-
sponse to exogenous laminin 5 while normal cells do not
(Gil, S.G., M.C. Ryan, and W.G. Carter, unpublished ob-
servation). Future studies will determine if exogenous
laminin 5 or transfection with a3-laminin cDNAs can rescue
cellular defects stemming from the removal of laminin 5.
Relationship to Other Knock-Out Animals
The integrity of the epidermis of LAMA3 null animals re-
mained intact during development and birth indicating
that adhesion independent of laminin 5 may provide suffi-
cient developmental instruction and stability for survival
before birth. Junctional blisters developed in the affected
pups several hours after birth and were usually restricted
to the forepaws, limbs, and oral mucosa. A similar blister-
ing phenotype was found in mice carrying a disruption in
the b3 subunit of laminin 5 that was caused by insertion of
an intracisternal-A particle into the LAMB3 gene (Kuster
et al., 1997). The relatively restricted blistering phenotype
of the LAMA3 null animals contrasts with the phenotype
of pups lacking integrin a6b4, the anchorage receptor for
laminin 5. Pups lacking either integrin a6 or b4 displayed
extensive blisters over the entire body surface and died
within hours of birth (Dowling et al., 1996; Georges-
Labouesse et al., 1996; van der Neut et al., 1996). The ex-Ryan et al. Targeted Disruption of the LAMA3 Gene 1321
tensive skin fragility may have been caused by weakening
in the cytoplasm and at the BMZ that resulted in the for-
mation of both simplex and junctional blisters in these ani-
mals (Dowling et al., 1996; Georges-Labouesse et al., 1996;
van der Neut et al., 1996). The epithelium in b4 null ani-
mals was also susceptible to apoptotic cell death. Using a
tunnel staining assay (data not shown), we did not detect
apoptosis in LAMA3 null animals. The accelerated and
heightened severity of the blistering in the b4 null animals
may also have contributed to the onset of apoptosis in
these animals. We noted organization changes in the epi-
dermis of LAMA3 null animals that were similar to the b4
null animals. In particular, we identified cell clusters that
appeared undifferentiated in the superbasal cell layer sim-
ilar to the pearl cells described in the b4 null animals
(Dowling et al., 1996). Immunostaining of skin with anti-
b4 antibodies identified positive staining in the superbasal
cell layer (data not shown), suggesting that cellular differ-
entiation in lesional regions of the epidermis may be ab-
normal in LAMA3 null animals.
Laminin 5 can regulate both anchorage and motility of
epithelial cells through integrin a6b4 and a3b1, respec-
tively (Carter et al., 1990; Xia et al., 1996; Goldfinger et al.,
1998). Consistently, analysis of skin from integrin a3 null
animals has revealed alterations in the epidermis stem-
ming from the absence of integrin a3b1 function (DiPersio
et al., 1997). In particular, the integrin a3 null animals
showed a disorganized BM and blister formation at the
dermal–epidermal junction (DiPersio et al., 1997). Similar
to LAMA3 null animals, bleeding was identifiable in the
paws of integrin a3 null pups (Hodivala-Dilke et al., 1998).
Whether these two observations are connected remains to
be determined. The bleeding that occurred in the paws of
the LAMA3 null pups was detectable even before a blister
had formed, suggesting that it was a primary defect. The
bleeding may be an indication of an abnormality stemming
from the role of a3-laminin in an alternative trimer such as
laminin 6 or 7.
The BM of Mutant Tissue Supports b1-Integrin 
Function, but Not a6b4-Anchorage
Using a novel adhesion assay to directly assay BM func-
tion in vivo we found that the mutant BM could no longer
induce adhesion by integrin a6b4. These results confirm
that functional interactions between integrin a6b4 and
laminin 5 have been eliminated in homozygous null ani-
mals. This data has implications for the organism as a
whole because it indicates that integrin a6b4 may be unli-
gated or no longer functional in multiple tissues, which
may contribute to the neonatal lethality in homozygous
null animals. In contrast to loss of a6b4 function, cell ad-
hesion via integrin a3b1 was retained in the mutant BM.
Because we have demonstrated that laminin 5 is absent
from the mutant BM, the most logical conclusion is that
we are detecting an alternative ligand for integrin a3b1
that is present in the BM of mutant skin. Our immu-
nostaining experiments have identified several laminin
isoforms which may be candidate ligands for integrin a3b1
in the epidermal BM (Table I). In a recent study that com-
pared the ligand binding activities of different laminin iso-
forms, laminin 10/11 was identified as a potent substrate
for adhesion of lung carcinoma cells via integrin a3b1
(Kikkawa et al., 1998). The a3b1-mediated adhesion to
laminin 10/11 was comparable to laminin 5 and found to
be greater than adhesion to laminin 1 or laminin 2/4
(Kikkawa et al., 1998). Likewise, we have shown that ad-
hesion of HFKs via integrin a3b1 is better on laminin 5
than on laminin 1, suggesting that laminin 1 does not sig-
nificantly contribute to adhesion of keratinocytes in vivo
(Carter et al., 1990). Accordingly, laminin 10/11 or a new
laminin isoform may contribute to a3b1-mediated adhe-
sion and will be investigated as a possible second ligand
for integrin a3b1 in epidermis.
Laminin 5 Regulates Late Stage Differentiation
of Epithelium
We have established a role for laminin 5 in late stage dif-
ferentiation of ameloblasts in developing incisors of mu-
tant animals. The phenotypic alterations found in mutant
incisors are consistent with the dental abnormalities and
enamel hypoplasia described for JEB-G patients (Brain
and Wigglesworth, 1968; Gardner and Hudson, 1975).
Enamel hypoplasia has also been reported for an epider-
molysis bullosa patient with a confirmed mutation in the
ITGB4 gene (Pulkkinen et al., 1998b), implicating a role
for integrin a6b4 in amelogenesis. In our studies, amelo-
blast abnormalities were first detected at the onset of
enamel secretion and continued throughout ameloblast
differentiation, culminating in the disorganization of the
reduced enamel epithelium. The phenotypic alterations
coincided nicely with the deposition of a3-laminin trimers
in the wild-type incisor where we identified positive stain-
ing for the laminin a3 chain along the edge of the differen-
tiating ameloblasts. No staining was detected in a compa-
rable region of the mutant incisor, confirming the absence
of laminin 5 in the mutant tooth. Positive staining for inte-
grin b4 (data not shown) suggests that the ameloblast dif-
ferentiation may be dependent on laminin 5 interactions
with integrin a6b4. The deposition of laminin a3 chain in
the wild-type tooth is consistent with recent studies that
have shown that the subunits of laminin 5 are expressed in
differentiating ameloblasts, even during enamel secretion
when laminin 1 expression has disappeared (Salmivirta et al.,
1997; K. Yoshiba et al., 1998; N. Yoshiba et al., 1998). It is
interesting that abnormalities were detected in the mutant
tooth at the onset of enamel secretion because ultrastruc-
tural analysis of developing teeth have shown that the
basal lamina disappears during the secretory stage of
amelogenesis and then reforms during ameloblast matura-
tion (Smith, 1998). Our results suggest that laminin 5 has a
unique role in regulation of ameloblast differentiation and
that the requirement for laminin 5 may begin at the onset
of enamel secretion. Furthermore, the disorganization that
occurred in the reduced enamel epithelium emphasizes a
role for laminin 5 in the maintenance of stratified epithe-
lium.
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